NEW YORK (Reuters Health) – In older patients with normal lipids but high C-reactive protein, primary prevention therapy with rosuvastatin (Crestor) does not lower mortality, but it does…
NEW YORK (Reuters Health) – Anemia increases the risk of bleeding and death after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), a new study shows.…
NEW YORK (Reuters Health) – Prostate specific antigen (PSA) doubling time as measured before radical prostatectomy does not predict biochemical progression after surgery, according to a report in…
NEW YORK (Reuters Health) – A comparison of 10 seizure drugs in older epilepsy patients shows that lamotrigine is the most effective — based on 12-month retention and…
NEW YORK (Reuters Health) – Intra-arterial fibrinolysis improves outcomes after acute ischemic stroke, a meta-analysis confirms — and although the treatment increases the risk of hemorrhage, that doesn’t…
NEW YORK (Reuters Health) – Urinary dipstick and microscopy testing are not good at finding urinary tract infection when pain is not one of the symptoms, UK researchers…
NEW YORK (Reuters Health) – Patients on long-term stable warfarin therapy can safely be immunized against influenza, results of study from Italy indicate. In the study, influenza vaccination…
NEW YORK (Reuters Health) – Polymerase chain reaction (PCR) analysis of dried blood spots is an insensitive means of neonatal screening for cytomegalovirus (CMV) infection, a large study…
NEW YORK (Reuters) – In older patients on warfarin therapy, treatment with cotrimoxazole significantly raises the risk of upper gastrointestinal tract hemorrhage, new research shows. The increased hemorrhage…
NEW YORK (Reuters Health) – In adults with moderate-to-severe active Crohn’s disease, treatment with infliximab plus azathioprine, or infliximab alone, led to significantly higher rates of corticosteroid-free clinical…